We welcome you to the AZ Biopharm GmbH home page. We are an independent FDA registered and GLP / GMP / GCP certified analytical laboratory in Berlin. Our work is characterized by speed, flexibility, passion for analytics, as well as individual and trustworthy contact to the client. We are happy to inform you on the following pages about our broad range of analytical services and offer you competently advise according to your individual needs without obligation. A personal contact person is always available to answer your questions.
Do not hesitate to contact us! We are looking forward to your inquiry!
Quality – made in Germany, all service from a single reliable supplier!Inquire now
AZ Biopharm Berlin
AZ Biopharm GmbH Berlin is a privately held company that operates for 25 years and has many years of experience in the field of analytics. The focus of our range of services is pharmaceutical quality control under GMP as well as bioanalytics of preclinical and clinical studies under GLP and GCP.
Experienced employees use state-of-the-art analytical equipment to process the studies and projects. The AZB guarantees our clients quality, fast reaction times as well as tailor-made and regulatory-compliant analytical solutions.
As an attractive employer with opportunities for personal development and a low fluctuation rate, the development of the Analytical Center Berlin (AZB) is also directed towards high continuity. Our employees appreciate the cooperative and exiting work environment and bring their enthusiasm into the timely and quality-oriented completion of the analytics.
AZ-Biopharm will participate on the N° 13 EBF Open Symposium – “From Cyberspace – Staying Connected”, 17-20 November 2020.
Press release BfArM October 16, 2020
The EU supervisory authorities require nitrosamine tests on medicinal products containing metformin.
„The European Medicines Agency (EMA) and the responsible national authorities in the EU will contact all marketing authorization holders of metformin-containing medicinal products and ask them to test all metformin-containing finished medicinal products for the presence of nitrosamines before they are released to the market.
Meanwhile almost all countries are affected by the virus spread putting many especially elderly people on high risk to die. And although in a few countries one observes that the infection rates are slowing down and scientists around the world are doing a great job to discover a vaccine, there is no mid-term solution for an effective vaccine on the horizon.